Found: 33
Select item for more details and to access through your institution.
The Dual GLP-1/GIP Receptor Agonist DA4-JC Shows Superior Protective Properties Compared to the GLP-1 Analogue Liraglutide in the APP/PS1 Mouse Model of Alzheimer's Disease.
- Published in:
- American Journal of Alzheimer's Disease & Other Dementias, 2020, v. 35, p. 1, doi. 10.1177/1533317520953041
- By:
- Publication type:
- Article
Molecular Properties and Therapeutic Targeting of the EBV-Encoded Receptor BILF1.
- Published in:
- Cancers, 2021, v. 13, n. 16, p. 4079, doi. 10.3390/cancers13164079
- By:
- Publication type:
- Article
Structure-function guided modeling of chemokine-GPCR specificity for the chemokine XCL1 and its receptor XCR1.
- Published in:
- Science Signaling, 2019, v. 12, n. 597, p. 1, doi. 10.1126/scisignal.aat4128
- By:
- Publication type:
- Article
A Pilot Study Showing Acute Inhibitory Effect of GLP‐1 on the Bone Resorption Marker CTX in Humans.
- Published in:
- JBMR Plus, 2019, v. 3, n. 10, p. N.PAG, doi. 10.1002/jbm4.10209
- By:
- Publication type:
- Article
The Role of Incretins on Insulin Function and Glucose Homeostasis.
- Published in:
- Endocrinology, 2021, v. 162, n. 7, p. 1, doi. 10.1210/endocr/bqab065
- By:
- Publication type:
- Article
Methods for Studying Endocytotic Pathways of Herpesvirus Encoded G Protein-Coupled Receptors.
- Published in:
- Molecules, 2020, v. 25, n. 23, p. 5710, doi. 10.3390/molecules25235710
- By:
- Publication type:
- Article
GPR183 Is Dispensable for B1 Cell Accumulation and Function, but Affects B2 Cell Abundance, in the Omentum and Peritoneal Cavity.
- Published in:
- Cells (2073-4409), 2022, v. 11, n. 3, p. 494, doi. 10.3390/cells11030494
- By:
- Publication type:
- Article
Enhanced agonist residence time, internalization rate and signalling of the GIP receptor variant [E354Q] facilitate receptor desensitization and long‐term impairment of the GIP system.
- Published in:
- Basic & Clinical Pharmacology & Toxicology, 2020, v. 126, p. 122, doi. 10.1111/bcpt.13289
- By:
- Publication type:
- Article
l-valine is a powerful stimulator of GLP-1 secretion in rodents and stimulates secretion through ATP-sensitive potassium channels and voltage-gated calcium channels.
- Published in:
- Nutrition & Diabetes, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41387-024-00303-4
- By:
- Publication type:
- Article
The C-terminal peptide of CCL21 drastically augments CCL21 activity through the dendritic cell lymph node homing receptor CCR7 by interaction with the receptor N-terminus.
- Published in:
- Cellular & Molecular Life Sciences, 2021, v. 78, n. 21/22, p. 6963, doi. 10.1007/s00018-021-03930-7
- By:
- Publication type:
- Article
GIP as a Therapeutic Target in Diabetes and Obesity: Insight From Incretin Co-agonists.
- Published in:
- 2020
- By:
- Publication type:
- journal article
The Antiresorptive Effect of GIP, But Not GLP‐2, Is Preserved in Patients With Hypoparathyroidism—A Randomized Crossover Study.
- Published in:
- Journal of Bone & Mineral Research, 2021, v. 36, n. 8, p. 1448, doi. 10.1002/jbmr.4308
- By:
- Publication type:
- Article
A Blunted GPR183/Oxysterol Axis During Dysglycemia Results in Delayed Recruitment of Macrophages to the Lung During Mycobacterium tuberculosis Infection.
- Published in:
- 2022
- By:
- Publication type:
- journal article
64-OR: Postprandial Effects of Endogenous Glucose-Dependent Insulinotropic Polypeptide in Type 2 Diabetes.
- Published in:
- Diabetes, 2019, v. 68, p. N.PAG, doi. 10.2337/db19-64-OR
- By:
- Publication type:
- Article
1976-P: Physiological Effects of GIP(1-30)NH<sub>2</sub> in Healthy Subjects.
- Published in:
- Diabetes, 2019, v. 68, p. N.PAG, doi. 10.2337/db19-1976-P
- By:
- Publication type:
- Article
The Gluco- and Liporegulatory and Vasodilatory Effects of Glucose-Dependent Insulinotropic Polypeptide (GIP) Are Abolished by an Antagonist of the Human GIP Receptor.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Biased GLP‐2 agonist with strong G protein‐coupling but impaired arrestin recruitment and receptor desensitization enhances intestinal growth in mice.
- Published in:
- British Journal of Pharmacology, 2023, v. 180, n. 13, p. 1674, doi. 10.1111/bph.16040
- By:
- Publication type:
- Article
Glucose-dependent insulinotropic polypeptide receptor antagonist treatment causes a reduction in weight gain in ovariectomised high fat diet-fed mice.
- Published in:
- 2022
- By:
- Publication type:
- journal article
N‐terminal alterations turn the gut hormone GLP‐2 into an antagonist with gradual loss of GLP‐2 receptor selectivity towards more GLP‐1 receptor interaction.
- Published in:
- British Journal of Pharmacology, 2022, v. 179, n. 18, p. 4473, doi. 10.1111/bph.15866
- By:
- Publication type:
- Article
Gut Hormones and Their Effect on Bone Metabolism. Potential Drug Therapies in Future Osteoporosis Treatment.
- Published in:
- Frontiers in Endocrinology, 2019, p. N.PAG, doi. 10.3389/fendo.2019.00075
- By:
- Publication type:
- Article
GPR183 Regulates Interferons, Autophagy, and Bacterial Growth During Mycobacterium tuberculosis Infection and Is Associated With TB Disease Severity.
- Published in:
- Frontiers in Immunology, 2020, v. 11, p. N.PAG, doi. 10.3389/fimmu.2020.601534
- By:
- Publication type:
- Article
The Location of Missense Variants in the Human GIP Gene Is Indicative for Natural Selection.
- Published in:
- Frontiers in Endocrinology, 2022, v. 13, p. 1, doi. 10.3389/fendo.2022.891586
- By:
- Publication type:
- Article
Author Correction: Amantadine inhibits known and novel ion channels encoded by SARS-CoV-2 in vitro.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
Amantadine has potential for the treatment of COVID-19 because it inhibits known and novel ion channels encoded by SARS-CoV-2.
- Published in:
- Communications Biology, 2021, v. 4, n. 1, p. 1, doi. 10.1038/s42003-021-02866-9
- By:
- Publication type:
- Article
High incidence of imperforate vagina in ADGRA3-deficient mice.
- Published in:
- BMC Biology, 2024, v. 22, n. 1, p. 1, doi. 10.1186/s12915-024-01873-6
- By:
- Publication type:
- Article
Increased Body Weight and Fat Mass After Subchronic GIP Receptor Antagonist, but Not GLP-2 Receptor Antagonist, Administration in Rats.
- Published in:
- Frontiers in Endocrinology, 2019, p. 1, doi. 10.3389/fendo.2019.00492
- By:
- Publication type:
- Article
Sustained effect of glucagon on body weight and blood glucose: Assessed by continuous glucose monitoring in diabetic rats.
- Published in:
- PLoS ONE, 2018, v. 13, n. 3, p. 1, doi. 10.1371/journal.pone.0194468
- By:
- Publication type:
- Article
Dendritic Cells and CCR7 Expression: An Important Factor for Autoimmune Diseases, Chronic Inflammation, and Cancer.
- Published in:
- International Journal of Molecular Sciences, 2021, v. 22, n. 15, p. 8340, doi. 10.3390/ijms22158340
- By:
- Publication type:
- Article
Publisher Correction: Reply to: How many SARS-CoV-2 "viroporins" are really ion channels?
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
Reply to: How Many SARS-CoV-2 "Viroporins" Are Really Ion Channels?
- Published in:
- Communications Biology, 2022, v. 5, n. 1, p. 1, doi. 10.1038/s42003-022-03670-9
- By:
- Publication type:
- Article
Biased agonism and allosteric modulation of G protein-coupled receptor 183 - a 7TM receptor also known as Epstein-Barr virus-induced gene 2.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Three-Dimensional Explant Platform for Studies on Choroid Plexus Epithelium.
- Published in:
- Frontiers in Cellular Neuroscience, 2020, v. 14, p. 1, doi. 10.3389/fncel.2020.00108
- By:
- Publication type:
- Article
Selective Boosting of CCR7-Acting Chemokines; Short Peptides Boost Chemokines with Short Basic Tails, Longer Peptides Boost Chemokines with Long Basic Tails.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 3, p. 1397, doi. 10.3390/ijms23031397
- By:
- Publication type:
- Article